DrugPatentWatch Database Preview
Patent: 9,775,844
» See Plans and Pricing
Summary for Patent: 9,775,844
| Title: | Heterocyclic compounds and uses thereof |
| Abstract: | Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. |
| Inventor(s): | Kutok; Jeffery L. (Natick, MA), Winkler; David G. (Arlington, MA), Palombella; Vito J. (Needham, MA), Castro; Alfredo C. (Woburn, MA), Evans; Catherine A. (Somerville, MA), Janardanannair; Somarajannair (Woburn, MA), Lescarbeau; Andre (Somerville, MA), Liu; Tao (Wellesley, MA), Tremblay; Martin R. (Melrose, MA) |
| Assignee: | Infinity Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 14/661,656 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,775,844
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125554 | 001 | 2015-11-23 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | Orphan | search |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 002 | 2015-03-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 001 | 2015-03-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| Merck Sharp Dohme | KEYTRUDA | pembrolizumab | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER | 125514 | 001 | 2014-09-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | Orphan | search |
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,775,844
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015143012 | Start Trial |
| United States of America | 10675286 | Start Trial |
| United States of America | 2015290207 | Start Trial |
| United States of America | 2018055852 | Start Trial |
| Singapore | 10201808053X | Start Trial |
| Singapore | 11201607705X | Start Trial |
| Philippines | 12016501809 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
